Why does sodium sieving occur in peritoneal dialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Why Sodium Sieving Occurs in Peritoneal Dialysis

Sodium sieving in peritoneal dialysis occurs because water is transported faster than sodium across the peritoneal membrane through aquaporin-1 water channels during periods of high osmotic ultrafiltration, creating a dilutional effect where the dialysate sodium concentration temporarily drops below plasma levels.

Mechanism of Sodium Sieving

The phenomenon is fundamentally a consequence of dissociated transport pathways for water versus solutes 1, 2:

  • Aquaporin-1 mediated water transport: When hypertonic glucose solutions create a strong osmotic gradient, water moves rapidly through aquaporin-1 channels in peritoneal capillary endothelium
  • Slower sodium diffusion: Sodium moves primarily through larger intercellular pores via diffusion and convection, but at a much slower rate than pure water transport
  • Result: During the early phase of hypertonic dwells (especially first 60-90 minutes), water enters the peritoneal cavity faster than sodium, diluting the dialysate sodium concentration below the patient's plasma sodium level 3, 4

This creates the characteristic "sodium dip" - a temporary decrease in dialysate-to-plasma (D/P) sodium ratio that reaches its minimum around 60 minutes into a hypertonic dwell 4, 5.

Clinical Significance and Timing

The sodium sieving effect is most pronounced with:

  • Short-duration dwells (1-2 hours) using hypertonic glucose solutions 6, 7
  • Automated peritoneal dialysis (APD) with multiple rapid exchanges 6
  • Higher glucose concentrations (3.86%/4.25% solutions) that create stronger osmotic gradients 4

In pediatric APD patients, sodium removal per liter of ultrafiltration can be as low as 4.6-5.3 g/L with 1-2 hour dwells, compared to the standard 7.5 g/L expected in adult CAPD 7. This means less sodium is removed relative to water volume, potentially leading to sodium accumulation despite adequate ultrafiltration.

Clinical Implications for Blood Pressure and Volume Control

The sodium sieving effect in APD can compromise blood pressure and volume control 6:

  • Multiple short overnight dwells (4 exchanges over 8 hours) maximize sodium sieving
  • Long day dwells allow salt and water resorption back into the patient
  • The combination results in inadequate net sodium removal despite seemingly adequate ultrafiltration volumes

Strategies to Minimize Sodium Sieving Problems 6:

  1. Reduce overnight exchange frequency: Use fewer than 4 exchanges during 8-hour nighttime (current US average is already <4)
  2. Manage the long dwell:
    • Shorten day dwell by draining and either adding midday exchange OR having "dry time"
    • Use icodextrin for long dwells (day dwell in APD, night dwell in CAPD)
  3. Icodextrin advantage: Creates ultrafiltration via colloid osmosis rather than crystalloid osmosis, so aquaporins play minimal role and sodium sieving is absent 2

Pathological Implications

Loss of sodium sieving can indicate serious peritoneal membrane pathology 4:

  • Normal peritoneum shows decreased D/P sodium ratio at 60 minutes during hypertonic dwells
  • Absence of this sodium dip suggests impaired transcellular water transport
  • This is associated with severe ultrafiltration failure and may indicate:
    • Glycosylation of membrane proteins
    • Peritoneal fibrosis with impaired free water transport 1
    • Risk of progression to sclerosing peritonitis

In one study, patients lacking the normal sodium sieving pattern had ultrafiltration differences of only 153 mL between 3.86% and 1.36% glucose (versus 569 mL in controls), and most required transfer to hemodialysis 4.

Practical Monitoring

The sodium dip can actually be used clinically as a novel method to estimate ultrafiltration and osmotic conductance 5. A single dialysate sodium measurement during a hypertonic dwell, when incorporated into mathematical models, correlates well with volumetric ultrafiltration measurements (R² = 0.76) and can calculate osmotic conductance to glucose (Pearson r = 0.77).

Key clinical caveat: When evaluating APD patients with hypertension or volume overload, recognize that adequate drain volumes do not guarantee adequate sodium removal due to sodium sieving 6. The prescription must be individualized with attention to both ultrafiltration profile AND sodium removal, particularly avoiding the combination of multiple short dwells plus long reabsorptive dwells.

References

Research

Can Free Water Transport Be Used as a Clinical Parameter for Peritoneal Fibrosis in Long-Term PD Patients?

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2016

Research

Sodium sieving in children.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2005

Research

Transperitoneal transport of sodium during hypertonic peritoneal dialysis.

Clinical physiology (Oxford, England), 1996

Research

Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD?

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1995

Guideline

clinical practice guidelines for peritoneal dialysis adequacy.

American Journal of Kidney Diseases, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.